ArticleEuropean journal of heart failure2025

Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study.

Stephen J Greene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.